Discovery of HZ-L105, a Next Generation of Bcl-2 Inhibitor, Overcomes Bcl-2 Mutation and Exhibits Superior Antitumor Activity
Saved in:
Published in | Blood Vol. 140; no. Supplement 1; pp. 7798 - 7799 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
15.11.2022
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!